We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

78 hedge funds and large institutions have $378M invested in VanEck Biotech ETF in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

74% more capital invested

Capital invested by funds: $217M → $378M (+$161M)

15% more funds holding

Funds holding: 68 → 78 (+10)

13.06% more ownership

Funds ownership: 35.66% → 48.72% (+13%)

4% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 24

58% less call options, than puts

Call options by funds: $3.04M | Put options by funds: $7.19M

Holders
78
Holders Change
+10
Holders Change %
+14.71%
% of All Funds
2.08%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
23
Reduced
24
Closed
5
Calls
$3.04M
Puts
$7.19M
Net Calls
-$4.15M
Net Calls Change
-$5.6M

Top Buyers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
+$55.7M
2
Goldman Sachs
Goldman Sachs
New York
+$53.3M
3
VF
Virtu Financial
New York
+$15.3M
4
TRCT
Tower Research Capital (TRC)
New York
+$4.67M
5
Jane Street
Jane Street
New York
+$4.05M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.96M
2
UBS Group
UBS Group
Switzerland
-$3.13M
3
AP
Advisors Preferred
Maryland
-$2.39M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.93M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
WJA
26
Williams Jones & Associates
New York
$2.09M +$267K +2,125 +15%
KCM
27
Karp Capital Management
California
$2.08M +$263K +2,095 +15%
BRM
28
Boston Research & Management
Massachusetts
$2.05M -$12.6K -100 -0.6%
VKH
29
Virtu KCG Holdings
New York
$1.97M +$1.91M +15,236 New
SG Americas Securities
30
SG Americas Securities
New York
$1.85M – – –
AFG
31
Albion Financial Group
Utah
$1.75M -$149K -1,186 -8%
CM
32
Churchill Management
California
$1.54M -$343K -2,728 -19%
Commonwealth Equity Services
33
Commonwealth Equity Services
Massachusetts
$1.53M +$57.4K +457 +4%
NPC
34
National Planning Corporation
California
$1.52M +$220K +1,753 +17%
Citadel Advisors
35
Citadel Advisors
Florida
$1.13M +$758K +6,031 +222%
AIG
36
American International Group
New York
$1.11M +$375K +2,988 +54%
Stifel Financial
37
Stifel Financial
Missouri
$907K +$126K +1,000 +17%
NCM
38
Niemann Capital Management
Nevada
$864K -$52.7K -419 -6%
GJIC
39
Gamble Jones Investment Counsel
California
$777K – – –
HighTower Advisors
40
HighTower Advisors
Illinois
$689K +$88K +700 +15%
AIC
41
Ayalon Insurance Company
Israel
$648K +$628K +5,000 New
IAMOG
42
Investors Asset Management of Georgia
Georgia
$479K – – –
Cambridge Investment Research Advisors
43
Cambridge Investment Research Advisors
Iowa
$468K -$15.6K -124 -3%
PTC
44
Private Trust Company
Ohio
$454K -$126K -1,000 -22%
Millennium Management
45
Millennium Management
New York
$432K +$419K +3,336 New
FAAS
46
First Allied Advisory Services
California
$422K +$410K +3,264 New
MFS
47
MSI Financial Services
Massachusetts
$407K +$63.2K +503 +19%
First Manhattan
48
First Manhattan
New York
$388K – – –
AB
49
Atlas Brown
Kentucky
$387K +$375K +2,985 New
JP Morgan Chase
50
JP Morgan Chase
New York
$383K +$372K +2,958 New
1
2
3 4

BBH Hedge Fund Activity: Q1 2015 in Review

78 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2015, worth a combined $378M — up 74% from $217M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 5 closed out — a net gain of 11 holders — while 23 added to existing stakes and 24 trimmed.

The largest buyer was Credit Suisse, adding an estimated $55.7M. The largest seller was Morgan Stanley, cutting an estimated $5.96M.

  • 78 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2015, up from 68 in Q4 2014.
  • Funds reported $378M of VanEck Biotech ETF stock for Q1 2015, up 74% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q1 2015 and 5 closed out, a net change of +11 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2015 was Credit Suisse, an estimated $55.7M added.
  • The largest VanEck Biotech ETF seller in Q1 2015 was Morgan Stanley, an estimated $5.96M sold.

Based on aggregated 13F filings for Q1 2015.